vimarsana.com
Home
Live Updates
InnoSIGN Completes Spin-Out from Philips with an $8M Series
InnoSIGN Completes Spin-Out from Philips with an $8M Series
InnoSIGN Completes Spin-Out from Philips with an $8M Series A Financing to Revolutionize Precision Medicine through its OncoSIGNal Pathway Activity Profiling Platform
InnoSIGN utilizes its proprietary database with over 100,000 pathway activity profiles for drug development and diagnostics to predict patient response to targeted therapies Proceeds support
Related Keywords
De Wiel ,
Friesland ,
Netherlands ,
Dutch ,
Henk Van Houten ,
Innosign Inc ,
Brabant Development Agency ,
Philips Research ,
Philips ,
Head Of Research Philips ,
Royal Philips ,
Casdin Capital ,
Life Science Angels ,
Thuja Capital ,
Brabant Development ,
High Tech Campus ,
Callan May ,
Innosign ,
Ompletes ,
Spin ,
Rom ,
Series ,
Financing ,
Evolutionize ,
Precision ,
Medicine ,
Through ,
Ncosignal ,
Pathway ,
Activity ,
Profiling ,
Platform ,